CLSA President & CEO Sara Radcliffe to Participate in 14th Annual BIO Investor Forum Advisory Committee
SOUTH SAN FRANCISCO – August 14, 2015 – California Life Sciences Association (CLSA) is pleased to announce that Sara Radcliffe, President & CEO of CLSA, has been chosen to participate on this year’s BIO Investor Forum Advisory Committee. The BIO Investor Forum, an international biotech investor conference focused on early and established private companies as well as emerging public companies, will take place October 20-21, 2015 at the Parc 55 Hilton in San Francisco. The conference will explore trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2015.
The BIO Investor Forum Advisory Committee comprises influential members of the life sciences community who are shaping the climate of growth, investment and business creation today. In this capacity, Radcliffe will play an instrumental role in providing input on the agenda, program topics, and speaker selection.
“As a committee member, I look forward to working to ensure that the BIO Investor Forum and its programming supports the life science investment community’s business strategies,” said Sara Radcliffe, CLSA President & CEO. “The BIO Investor Forum has become the preeminent event for emerging private and newly public companies in the life sciences. Working in partnership with my fellow committee members, the BIO organization, the team at CLSA, and the life sciences investment community, we will grow the life sciences innovation ecosystem.”
For more information about the BIO Investor Forum, please visit www.bio.org/investorforum.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California’s life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California’s life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state’s most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Manager, Communications for CLSA